Vidisha Singh

999 total citations
16 papers, 357 citations indexed

About

Vidisha Singh is a scholar working on Epidemiology, Infectious Diseases and Surgery. According to data from OpenAlex, Vidisha Singh has authored 16 papers receiving a total of 357 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Epidemiology, 8 papers in Infectious Diseases and 5 papers in Surgery. Recurrent topics in Vidisha Singh's work include SARS-CoV-2 and COVID-19 Research (6 papers), HIV Research and Treatment (4 papers) and Virology and Viral Diseases (4 papers). Vidisha Singh is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (6 papers), HIV Research and Treatment (4 papers) and Virology and Viral Diseases (4 papers). Vidisha Singh collaborates with scholars based in United States, Germany and United Kingdom. Vidisha Singh's co-authors include Elissa Meites, Lauri E. Markowitz, Robert T. Chen, Elizabeth R. Unger, Ann Chahroudi, David K. Clarke, Stephen Seligman, James S. Robertson, R. Michael Hendry and Amir Dashti and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Immunology and The Journal of Immunology.

In The Last Decade

Vidisha Singh

14 papers receiving 344 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Vidisha Singh United States	12	198	144	65	59	46	16	357
Veronica Santilli Italy	11	139 0.7×	132 0.9×	49 0.8×	141 2.4×	64 1.4×	34	356
Shelly Karuna United States	11	131 0.7×	59 0.4×	47 0.7×	51 0.9×	107 2.3×	29	273
Chien-Hsiung Pan United States	10	156 0.8×	224 1.6×	66 1.0×	130 2.2×	17 0.4×	12	375
Cathleen Collins United States	11	60 0.3×	174 1.2×	99 1.5×	116 2.0×	7 0.2×	22	413
Yeu-Yao Cheng United States	8	52 0.3×	187 1.3×	49 0.8×	56 0.9×	26 0.6×	19	331
Carolyn M. Boudreau United States	7	184 0.9×	154 1.1×	62 1.0×	189 3.2×	23 0.5×	10	457
Erica Silberstein United States	12	155 0.8×	104 0.7×	97 1.5×	77 1.3×	9 0.2×	18	421
Ria Lassaunière Denmark	12	265 1.3×	131 0.9×	58 0.9×	80 1.4×	42 0.9×	33	442
LaSonji A. Holman United States	6	138 0.7×	123 0.9×	37 0.6×	61 1.0×	15 0.3×	6	301
Kim Blom Sweden	14	372 1.9×	140 1.0×	82 1.3×	314 5.3×	129 2.8×	31	786

Countries citing papers authored by Vidisha Singh

Since Specialization

Citations

This map shows the geographic impact of Vidisha Singh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vidisha Singh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vidisha Singh more than expected).

Fields of papers citing papers by Vidisha Singh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vidisha Singh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vidisha Singh. The network helps show where Vidisha Singh may publish in the future.

Co-authorship network of co-authors of Vidisha Singh

This figure shows the co-authorship network connecting the top 25 collaborators of Vidisha Singh. A scholar is included among the top collaborators of Vidisha Singh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vidisha Singh. Vidisha Singh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Dashti, Amir, Vidisha Singh, & Ann Chahroudi. (2022). Designing Cure Studies in NHPs. Methods in molecular biology. 2407. 215–228.

Singh, Vidisha, Stacey A. Lapp, Laila Hussaini, et al.. (2022). Limited induction of SARS-CoV-2–specific T cell responses in children with multisystem inflammatory syndrome compared with COVID-19. JCI Insight. 7(4). 11 indexed citations

Singh, Vidisha, Amir Dashti, Maud Mavigner, & Ann Chahroudi. (2021). Latency Reversal 2.0: Giving the Immune System a Seat at the Table. Current HIV/AIDS Reports. 18(2). 117–127. 26 indexed citations

Ravichandran, Supriya, Juanjie Tang, Gabrielle Grubbs, et al.. (2021). SARS-CoV-2 immune repertoire in MIS-C and pediatric COVID-19. Nature Immunology. 22(11). 1452–1464. 25 indexed citations

Meites, Elissa, Troy D. Querec, Laura S. Stone, et al.. (2021). Juvenile-Onset Recurrent Respiratory Papillomatosis in the United States, Epidemiology and HPV Types—2015–2020. Journal of the Pediatric Infectious Diseases Society. 10(7). 774–781. 13 indexed citations

Meites, Elissa, Laura S. Stone, Vidisha Singh, et al.. (2021). Significant Declines in Juvenile-onset Recurrent Respiratory Papillomatosis Following Human Papillomavirus (HPV) Vaccine Introduction in the United States. Clinical Infectious Diseases. 73(5). 885–890. 29 indexed citations

Monath, Thomas P., Patricia Fast, Kayvon Modjarrad, et al.. (2019). rVSVΔG-ZEBOV-GP (also designated V920) recombinant vesicular stomatitis virus pseudotyped with Ebola Zaire Glycoprotein: Standardized template with key considerations for a risk/benefit assessment. Vaccine X. 1. 100009–100009. 61 indexed citations

Singh, Vidisha, Beau Gratzer, Pamina M. Gorbach, et al.. (2019). Transgender Women Have Higher Human Papillomavirus Prevalence Than Men Who Have Sex With Men—Two U.S. Cities, 2012–2014. Sexually Transmitted Diseases. 46(10). 657–662. 35 indexed citations

Kochhar, Sonali, Jean‐Louis Excler, Karin Bok, et al.. (2018). Defining the interval for monitoring potential adverse events following immunization (AEFIs) after receipt of live viral vectored vaccines. Vaccine. 37(38). 5796–5802. 15 indexed citations

10.

Kose, Nurgun, D. Noah Sather, Gopal Sapparapu, et al.. (2018). Increased breadth of HIV-1 neutralization achieved by diverse antibody clones each with limited neutralization breadth. PLoS ONE. 13(12). e0209437–e0209437. 6 indexed citations

11.

Singh, Vidisha, Richard A. Crosby, Beau Gratzer, et al.. (2018). Disclosure of Sexual Behavior Is Significantly Associated With Receiving a Panel of Health Care Services Recommended for Men Who Have Sex With Men. Sexually Transmitted Diseases. 45(12). 803–807. 15 indexed citations

12.

Condit, Richard, Anna‐Lise Williamson, Rebecca Sheets, et al.. (2016). Unique safety issues associated with virus-vectored vaccines: Potential for and theoretical consequences of recombination with wild type virus strains. Vaccine. 34(51). 6610–6616. 32 indexed citations

13.

Clarke, David K., R. Michael Hendry, Vidisha Singh, et al.. (2016). Live virus vaccines based on a vesicular stomatitis virus (VSV) backbone: Standardized template with key considerations for a risk/benefit assessment. Vaccine. 34(51). 6597–6609. 51 indexed citations

14.

Bangaru, Sandhya, Travis Nieusma, Nurgun Kose, et al.. (2016). Recognition of influenza H3N2 variant virus by human neutralizing antibodies. JCI Insight. 1(10). 18 indexed citations

15.

Willis, Jordan R., Jessica A. Finn, Bryan Briney, et al.. (2016). Long antibody HCDR3s from HIV-naïve donors presented on a PG9 neutralizing antibody background mediate HIV neutralization. Proceedings of the National Academy of Sciences. 113(16). 4446–4451. 20 indexed citations

16.

Gilchuk, Iuliia M., David Blum, Vidisha Singh, et al.. (2014). Poxviral infection elicits human neutralizing antibodies recognizing diverse epitopes of the major vaccinia virus surface protein D8 (VIR4P.1016). The Journal of Immunology. 192(Supplement_1). 143.11–143.11.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact